Handok tries to extend additional indications of Tracleer tab.

Published: 2007-03-28 06:57:00
Updated: 2007-03-28 06:57:00
The indication of Tracleer tab., an anti pulmonary hypertension drug sold by Handok seems to extend to chronic thromboembolic pulmonary hypertension (CTEPH) based on the phase III clinical studies, Handok said on March 26.

Traclear tab. was originally developed by Actelion in Switzerland.

T...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.